PARP1 |
P09874
|
poly(ADP-ribose) polymerase 1
|
|
3.3E-04 |
0.389 |
0.923 |
BIN1 |
O00499
|
bridging integrator 1
|
|
0.78 |
0.550 |
0.692 |
ANXA5 |
P08758
|
annexin A5
|
|
3.8E-15 |
0.458 |
0.769 |
ANXA6 |
P08133
|
annexin A6
|
|
1.1E-08 |
0.514 |
0.846 |
APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
APEX1 |
P27695
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
|
1.9E-07 |
0.458 |
0.846 |
ARHGAP1 |
Q07960
|
Rho GTPase activating protein 1
|
|
0.77 |
0.638 |
0.577 |
CEACAM1 |
P13688
|
CEA cell adhesion molecule 1
|
|
7.9E-04 |
0.525 |
0.731 |
BMI1 |
P35226
|
BMI1 proto-oncogene, polycomb ring finger
|
|
0.94 |
0.448 |
0.808 |
BSG |
P35613
|
basigin (Ok blood group)
|
|
2.6E-05 |
0.458 |
0.769 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CDKN1A |
P38936
|
cyclin dependent kinase inhibitor 1A
|
|
1.9E-03 |
0.403 |
0.769 |
CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDKN3 |
Q16667
|
cyclin dependent kinase inhibitor 3
|
|
1.9E-03 |
0.514 |
0.769 |
CLU |
P10909
|
clusterin
|
|
7.8E-05 |
0.426 |
0.885 |
CRK |
P46108
|
CRK proto-oncogene, adaptor protein
|
|
0.96 |
0.394 |
0.923 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
CXADR |
P78310
|
CXADR Ig-like cell adhesion molecule
|
|
0.37 |
0.454 |
0.885 |
CYP2E1 |
P05181
|
cytochrome P450 family 2 subfamily E member 1
|
|
8.1E-09 |
0.459 |
0.885 |
DCN |
P07585
|
decorin
|
|
0.31 |
0.457 |
0.808 |
DDX3X |
O00571
|
DEAD-box helicase 3 X-linked
|
|
1.00 |
0.537 |
0.769 |
DIO3 |
P55073
|
iodothyronine deiodinase 3
|
|
0.62 |
0.593 |
0.731 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |